Michael R Nannenga, MD
Specialty
Endocrinology Diabetes & Metabolism
Languages
English
Seeing patients at
-
About Michael R Nannenga, MD
Dr. Michael Nannenga is a board-certified endocrinologist who has been serving patients at Holston Medical Group since 2011. He earned his medical degree from Indiana University School of Medicine and completed advanced residency and fellowship training through the Mayo Clinic. Dr. Nannenga focuses on endocrinology and metabolism, including thyroid disorders, diabetes and hormonal conditions. His approach to care centers on evidence-based medicine, education and helping patients successfully manage chronic conditions.Gender
Male
Employed or contracted
Employed
Network Name
Holston Medical Group
NPI
1922104975
-
Insurance Accepted
This list is for informational purposes only and may not reflect the most current plans accepted by the provider. Optum accepts most major health insurance plans. Please contact your insurance company to confirm your coverage, eligibility, and the provider's participation in your plan.
- Most major plans accepted
- please call to verify.
-
Education
Medical School
-
Indiana University School of Medicine
Indianapolis, IN
Residency
-
Mayo Clinic School of Graduate Medical Education
Rochester, MN
Fellowship
-
Mayo Clinic School of Graduate Medical Education
Rochester, MN
-
You are leaving Optum
You are now leaving Optum and going to a third-party website operated by Google. Optum is not responsible for the content or accuracy of the information on this third-party site. We recommend you review the third-party site's privacy policy and terms of use, as Optum's will no longer apply.
Leaving Optum.com
You are now leaving Optum.com to see Medicare plan choices through our partner site.
Data use
We use cookies and similar tools to make your use of this website easy and to keep it working properly. We may share data about you and how you use the site with third parties, such as analytics and marketing partners. Learn more in our Privacy Policy and Terms of Use. By continuing to use the site, you agree to this.